A Matched Case-Case-Control Study of the Impact of Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant

Humans Anti-Bacterial Agents / therapeutic use Bacterial Proteins / genetics beta-Lactamases / genetics Carbapenem-Resistant Enterobacteriaceae / genetics Carbapenems / therapeutic use Case-Control Studies Enterobacteriaceae Infections / drug therapy Japan Risk Factors
Enterobacteriaceae IMP carbapenem resistance clinical outcomes propensity score

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
17 02 2021
Historique:
received: 19 07 2020
accepted: 22 11 2020
pubmed: 2 12 2020
medline: 22 6 2021
entrez: 1 12 2020
Statut: epublish

Résumé

IMP-type carbapenemase, found in various Gram-negative bacteria, has been increasingly detected worldwide. We aimed to study the outcomes and risk factors for acquisition of IMP-type carbapenemase-producing carbapenem-resistant

Identifiants

DOI: 10.1128/AAC.01483-20 PMID: 33257451 PMC: PMC8092526
pubmed: 33257451
pii: AAC.01483-20
doi: 10.1128/AAC.01483-20
pmc: PMC8092526
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
beta-Lactamases EC 3.5.2.6
carbapenemase EC 3.5.2.6
Carbapenems 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 American Society for Microbiology.

Références

J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
Ann Clin Microbiol Antimicrob. 2018 Mar 23;17(1):13
pubmed: 29571291
Clin Microbiol Infect. 2014 Sep;20(9):831-8
pubmed: 24766097
Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):345-52
pubmed: 23001510
Sci Rep. 2017 Jul 27;7(1):6722
pubmed: 28751669
Clin Microbiol Rev. 2012 Oct;25(4):682-707
pubmed: 23034326
J Glob Antimicrob Resist. 2017 Dec;11:10-16
pubmed: 28743652
Infect Control Hosp Epidemiol. 2009 Dec;30(12):1180-5
pubmed: 19860564
J Infect Chemother. 2018 Sep;24(9):769-772
pubmed: 29656900
J Infect. 2018 May;76(5):438-448
pubmed: 29477802
Antimicrob Resist Infect Control. 2013 Dec 18;2(1):35
pubmed: 24345195
Clin Microbiol Infect. 2012 Jan;18(1):54-60
pubmed: 21722257
Antimicrob Agents Chemother. 2014;58(4):2322-8
pubmed: 24514083
Emerg Infect Dis. 2011 Oct;17(10):1791-8
pubmed: 22000347
J Clin Microbiol. 2003 Dec;41(12):5407-13
pubmed: 14662918
J Clin Microbiol. 2011 Dec;49(12):4239-45
pubmed: 21998425
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Antimicrob Chemother. 2016 Sep;71(9):2577-85
pubmed: 27197663
J Microbiol Methods. 2011 Dec;87(3):330-7
pubmed: 21986031
Lancet Infect Dis. 2011 May;11(5):381-93
pubmed: 21530894
Infect Control Hosp Epidemiol. 2005 Apr;26(4):346-51
pubmed: 15865269
J Hosp Infect. 2017 Nov;97(3):212-217
pubmed: 28736270
Antimicrob Agents Chemother. 2014 Jun;58(6):3441-50
pubmed: 24709261
Clin Infect Dis. 2017 Feb 1;64(3):257-264
pubmed: 28013264
Eur J Clin Microbiol Infect Dis. 2016 Mar;35(3):379-85
pubmed: 26740321
Ann Clin Microbiol Antimicrob. 2017 Jun 19;16(1):42
pubmed: 28629366
J Hosp Infect. 2017 Jun;96(2):111-115
pubmed: 28389093
J Antimicrob Chemother. 2007 Dec;60(6):1375-9
pubmed: 17913719
J Infect Chemother. 2019 Apr;25(4):240-246
pubmed: 30611637

Auteurs

Sho Saito (S)

Disease Control and Prevention Center, National Centre for Global Health and Medicine, Tokyo, Japan sho-87@hotmail.co.jp.
AMR Clinical Reference Center, National Centre for Global Health and Medicine, Tokyo, Japan.
Department of Emerging and Reemerging Infectious Diseases, Tohoku University School of Medicine, Sendai, Miyagi, Japan.
ORCID: 0000-0002-9981-7584

Kayoko Hayakawa (K)

Disease Control and Prevention Center, National Centre for Global Health and Medicine, Tokyo, Japan.
AMR Clinical Reference Center, National Centre for Global Health and Medicine, Tokyo, Japan.

Shinya Tsuzuki (S)

AMR Clinical Reference Center, National Centre for Global Health and Medicine, Tokyo, Japan.
Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Masahiro Ishikane (M)

Disease Control and Prevention Center, National Centre for Global Health and Medicine, Tokyo, Japan.
AMR Clinical Reference Center, National Centre for Global Health and Medicine, Tokyo, Japan.

Maki Nagashima (M)

Disease Control and Prevention Center, National Centre for Global Health and Medicine, Tokyo, Japan.

Kazuhisa Mezaki (K)

Microbiology Laboratory, National Center for Global Health and Medicine, Tokyo, Japan.

Yuko Sugiki (Y)

Infection Control and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.

Taichi Tajima (T)

AMR Clinical Reference Center, National Centre for Global Health and Medicine, Tokyo, Japan.

Nobuaki Matsunaga (N)

AMR Clinical Reference Center, National Centre for Global Health and Medicine, Tokyo, Japan.

Satoshi Ide (S)

Disease Control and Prevention Center, National Centre for Global Health and Medicine, Tokyo, Japan.
Department of Emerging and Reemerging Infectious Diseases, Tohoku University School of Medicine, Sendai, Miyagi, Japan.

Noriko Kinoshita (N)

Disease Control and Prevention Center, National Centre for Global Health and Medicine, Tokyo, Japan.
AMR Clinical Reference Center, National Centre for Global Health and Medicine, Tokyo, Japan.
Department of Emerging and Reemerging Infectious Diseases, Tohoku University School of Medicine, Sendai, Miyagi, Japan.

Yoshiki Kusama (Y)

AMR Clinical Reference Center, National Centre for Global Health and Medicine, Tokyo, Japan.
Department of Emerging and Reemerging Infectious Diseases, Tohoku University School of Medicine, Sendai, Miyagi, Japan.

Yumiko Fujitomo (Y)

AMR Clinical Reference Center, National Centre for Global Health and Medicine, Tokyo, Japan.

Takato Nakamoto (T)

Disease Control and Prevention Center, National Centre for Global Health and Medicine, Tokyo, Japan.

Yuta Toda (Y)

Disease Control and Prevention Center, National Centre for Global Health and Medicine, Tokyo, Japan.

Mitsuo Kaku (M)

Department of Infection Control and Laboratory Diagnostics, Tohoku University School of Medicine, Sendai, Miyagi, Japan.

Eiichi N Kodama (EN)

Division of Infectious Diseases, School of Medicine, International Research Institute of Disaster Science, and Tohoku Medical Megabank Organization, Tohoku University, Sendai, Miyagi, Japan.

Norio Ohmagari (N)

Disease Control and Prevention Center, National Centre for Global Health and Medicine, Tokyo, Japan.
AMR Clinical Reference Center, National Centre for Global Health and Medicine, Tokyo, Japan.
Department of Emerging and Reemerging Infectious Diseases, Tohoku University School of Medicine, Sendai, Miyagi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A Matched Case-Case-Control Study of the...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › A Matched Case-Case-Control Study of the...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines bactériennes › A Matched Case-Case-Control Study of the...
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Amidohydrolases › bêta-Lactamases › A Matched Case-Case-Control Study of the...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Enterobacteriaceae résistantes aux carbapénèmes › A Matched Case-Case-Control Study of the...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Carbapénèmes › A Matched Case-Case-Control Study of the...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études cas-témoins › A Matched Case-Case-Control Study of the...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Enterobacteriaceae › A Matched Case-Case-Control Study of the...
questionsmedicales.fr › Régions géographiques › Iles › Japon › A Matched Case-Case-Control Study of the...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › A Matched Case-Case-Control Study of the...